fbpx

Displaying items tagged: life sciences

Wednesday, 07 December 2022 11:23

PE-backed Burke Porter Group adds to life sciences portfolio with acquisition of Irish firm

ADA — Burke Porter Group is expanding its footprint to Ireland and bolstering its life sciences capabilities with the acquisition of a leading manufacturer of assembly products and storage solutions for the biomedical industry.

Published in Manufacturing
Wednesday, 23 November 2022 12:27

GR med device startup prepares implant material for commercialization after raising $5.3M

A Grand Rapids medical device startup aims to launch into the market in early 2023 with a new material for spinal and orthopedic implants.

Published in Health Care
Tuesday, 28 June 2022 11:09

Life sciences company investing up to $430M to revive former BASF site in Muskegon Twp.

MUSKEGON TWP. — A former BASF herbicide production facility in Muskegon County would return to life with a potential $430 million capital investment by Global Life Sciences Solutions USA LLC.

Published in Manufacturing

Thursday, 28 April 2022 16:16

$120M federal contract positions Grand River Aseptic Manufacturing for further growth

GRAND RAPIDS — A $120 million investment by the federal government will fund a large share of the cost for Grand River Aseptic Manufacturing Inc.’s latest expansion.

Published in Manufacturing
Friday, 23 July 2021 13:52

Tetra Therapeutics CEO Mark Gurney retires

EAST GRAND RAPIDS —Mark Gurney retired as CEO of drug developer Tetra Therapeutics Inc. at the end of June, more than a year after selling the company to Japan-based pharmaceutical company Shionogi & Co. Ltd.

Published in Health Care
Wednesday, 14 July 2021 10:02

Report: Michigan pharmaceutical, biotech construction remains strong with more to come

Construction projects within Michigan’s pharmaceutical and biotech industry totaled nearly $450 million between 2015 and 2020, according to an analysis that forecasts many more projects over the next half decade.

Published in Health Care

Wednesday, 19 May 2021 11:36

Contract research firm Kalexsyn names Brian Eklov as CEO

KALAMAZOO — Contract research organization Kalexsyn Inc. has named Brian Eklov as CEO.

Published in Health Care
Friday, 20 September 2019 09:50

Drug developer’s clinical trial enrollment going faster than expected

GRAND RAPIDS — Tetra Therapeutics says it is enrolling patients faster than expected for a clinical trial on a potential new drug to treat Alzheimer’s disease.

Published in Health Care